chrisvoncsefalvay/vaers-outcomes huggingface dataset:
is a 16-year-old female patient admitted with tachycardia.  Starting 1-1/2 weeks ago, mom notes that she has had episodes where she feels her heart racing.  It began 1-1/2 weeks ago with her crying and her watch that her heart rate was 208.  They went to the ED, where she was given some fluids and her heart rate improved so she was sent home.  She had had prior episodes of mild tachycardia up to the 140s in the past but which has always improved with fluids.  Mom states that she used to have a lot of trouble maintaining her hydration and would not drink a lot of water.  Since the last 1-1/2 weeks, she has been having these episodes 1-2 times a day that last about 1 to 2 minutes with a max of 5 minutes.  When it comes on, she feels dizzy and lightheaded, and after the episode she feels a big rush of blood to her head.  She also has some associated shortness of breath.  She denies having any episodes of chest pain at all.  She has never passed out, she has never felt like she was going to pass out, she has never felt like she was out of balance.  She denies any nausea or vomiting during episodes.  She denies any headaches during the episodes.  She does have history of migraines, but has not had one in the last couple weeks.  Her prior resting heart rate was in the 80s per her watch, and lately it has been in the 110s to 120s while awake in 80s while asleep.  Along with the episodes, she also feels some pulsating sensation in her abdomen.  She does not have any abdominal pain.  Today, her heart rate was again in the 200s, but it was worse than before because it lasted about 30 minutes total.  Lately they have been using an app that continuously monitors her heart rate.  Since these episodes started, she has cut down on her caffeine intake and she has increased her water intake.  Does not feel that this helped. She has never had syncope in the past and has never had seizures in the past.  Patient was started on carvedilol which has helped control heart rate and was encouraged to drink fluids. Per primary care team, her current episode of tachycardia was not due to the vaccine.
Pt vaccinated with Pneumovax 23 experienced swelling in the arm associated w/ m yalgia & headaches, intense local reaction, a temp 100.2, malaise, cephalgia, fatigue along w/a tendency towards motion sickness. Arm remained swollen w/bruise
BODY ACHES; SWEATING; MALAISE; FATIGUE; HEADACHE; This spontaneous report received from a parent concerned an 18 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, administered on 20-MAR-2021 13:00 to right arm for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, sweating, malaise, fatigue, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body aches, fatigue, sweating, headache and malaise was not reported. This report was non-serious.
Pt became pale, lightheaded. B/P 102/44 P60, no SOB. Visual signs monitored for next 1/2 hour, range 100/40 to 108/60, P 60-84, R 16-24. Pulse became irregular. Pt complained of burning eyes, itching left ear, elbow, leg. Called EMS, taken to hospital, treated with Benadryl .
Swelling, tenderness at the injection site and scattered vesicles. Advised cool compresses to area and Tylenol for discomfort.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  DEMAND ISCHEMIA ACUTE HYPERCAPNIC RESPIRATORY FAILURE 1/23/2023 --  RECURRENCE OF SAME SYMPTOMS
On evening of 11/18/03, patient reports vaccine site was red, swollen and tender to touch; he reports a knot about the size of a 50-cent piece at the site. Also, c/o fatigue and generalized muscle aches that evening; denies fever, chills or headaches.                                   On 11/19/03, swelling and redness at vaccine site had increased; patient continued to c/o fatigue and generalized muscle aches; later that afternoon, he c/o chills, generalized weakness, and left shoulder pain; he also said that it took extra effort to lift his left upper extremity above his head. He self-treated that night with ice to the vaccine site and to his left shoulder.                                       On 11/20/03, the swelling and redness surrounding his vaccine site had increased; he continued to have left shoulder pain, fatigue, generalized muscle aches and weakness. He sought evaluation; on exam, an area of approximately 80x80mm was indurated, and an area of approximately 160x100mm was erythematous surrounding the vaccine site; he had (+) axillary lymphadenopathy; temp 97.3; FROM of shoulder, elbow and wrist; he rated his level of pain as a 3 of 10 on pain scale; he was treated with Allegra q a.m., Benadryl q hs, and Motrin tid.                                     On 11/25/03, vaccine site with dime-sized knot; no redness or swelling; axillary lymphadenopathy dimished. Fatigue and weakness persist, but diminished.
The pt experienced urticaria, and vertigo. Treated with Prednisone and Allegra.
Pt felt sick that afternoon. Had a Fever of 104 degrees for 1½ days.
patient developed vesicular rash in dermatome distribution about 3 days after the 1st dose of Shingrix vaccine. She was seen by Primary care physician on 01/04/2022 and received treatment with Valacyclovir with improvement of the rash
fever of 38.3 Celsius; almost tennis ball size swelling of right under armpit; tingling and numbness in fingers/hand/some numbness right finger; tingling and numbness in fingers/hand; swelling of wrist; Chills; sweat; fatigue; no energy; Swollen upper arm, very painful; Swollen upper arm, very painful; pain also in former injection site for first dose; whole body sore; chest tightness; swelling left lymph node under armpit; tenderness of lymph node at right collar bone; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EW0182) via an unspecified route of administration in right arm on 14May2021 11:00 AM (age at vaccination 53-year-old) as dose 2 single, for COVID-19 immunisation at Pharmacy or Drug Store. The patient medical history included exercise and allergy induced asthma (mild). Patient was not pregnant at time of vaccination. Known allergies were none. No other vaccine in four weeks. The patient's concomitant medications in two weeks were none. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0161) on left arm on 23Apr2021 11:00 (age at 53-year-old) as dose 1 single for COVID-19 Immunization and 10 min after injection, patient experienced tingling in left hand/fingers, dizziness, and slight swelling of left wrist. Dizziness gone after 30 min. Chills and sweat (no measurable fever) during the night, general fatigue and ill feeling one day after vaccine. Swollen, painful lymph node under left arm (lasting about 2 weeks). It was reported that 5 min after injection on 14May2021 11:05 AM patient had tingling and numbness in fingers/hand, swelling of wrist. Chills and sweats (no fever), lasting through the night. Swollen upper arm, very painful, pain also in former injection site of first dose, whole body sore. Some chest tightness. Next morning body/arm soreness significantly better, still chills and sweats (no fever), almost tennis ball size swelling of right under armpit and tenderness of lymph node at right collar bone as well as slight swelling left lymph node under armpit. Fatigue, no energy, some numbness right finger. 29 h after injection on 15May2021 16:00, fever of 38.3 Celsius, lasting through the night. No treatment received for adverse events. No covid prior vaccination. No covid tested post vaccination. The outcome of all events was unknown.  No follow-up attempts possible. No further information expected.
Arm still red and swollen after 4 days; Arm still red and swollen after 4 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm still red and swollen after 4 days) and PERIPHERAL SWELLING (Arm still red and swollen after 4 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Arm still red and swollen after 4 days) and PERIPHERAL SWELLING (Arm still red and swollen after 4 days). At the time of the report, ERYTHEMA (Arm still red and swollen after 4 days) and PERIPHERAL SWELLING (Arm still red and swollen after 4 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Whole-body paresthesia more predominant in the face that developed 10 days after the second dose of the rabies vaccine series.
Recently admitted 11/27-11/28/21 for COVID-19 infection while neutropenic (s/p Pfizer vaccine 10/7/21 and 10/28/21). Sx started ~11/22 and tested positive for COVID-19 on 11/27/21. Started on remdesivir, but stable on RA, so dc'd on Levaquin x6 days and received Regeneron 11/29.
SHINGLES; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced shingles. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of shingles was not reported. This report was non-serious.
This spontaneous report as received from a Licensed Practical Nurse who refers to an unspecified group of patients of unknown age and gender. Patient's medical histories were not provided. On an unknown date the patients were vaccinated with improperly stored doses of (Oka/Merck) VARIVAX (dose, frequency, route of administration and indication were not provided) (lot # K003422, 06-MAR-2015). Concomitant medication was not reported. Firstly it was reported that (Oka/Merck) VARIVAX was stored at 75F. The reporting nurse subsequently called back and corrected the temperature range in which the (Oka/Merck) VARIVAX was improperly stored to 14.5F. No adverse effect was reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
approx 1 hrs p/vax pt had grand mal sx w/generalized activity; also had cyanosis; sx lasted 10-15mins per mom; pt did not stop breathing; mom called 911;  pt taken to ER t102-103;
Patient states her arm is sore and red at the injection site.  It started a week after she received the vaccine.  She has been advised by her physician to ice the affected area and take Tylenol for any pain.
This case was reported by a other health professional via call center representative and described the occurrence of fever in a 64-year-old male patient who received SHINGRIX (batch number 5MG5E, expiry date 21st May 2021) for prophylaxis. On 11th January 2019, the patient received SHINGRIX (intramuscular) .5 ml. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever, pain and hallucination. On an unknown date, the outcome of the fever, pain and hallucination were recovered/resolved. It was unknown if the reporter considered the fever, pain and hallucination to be related to SHINGRIX. Additional details were provided as follows: This case was reported by an Office Manager. The patient experienced fever, achiness and a hallucination after receiving SHINGRIX.
sluggish; tired; muscle aches; face on fire; chills; sweating; headache; This is a spontaneous report received from a contactable consumer. This 63-year-old female consumer (patient). A 63-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EN6203), via an unspecified route of administration, administered in the left arm as dose 2, single on 16Mar2021 09:30 (at the age of 63-year-old) for COVID-19 immunisation. The patient's medical history included multiple sclerosis from an unknown date and unknown if ongoing. Historical vaccine included received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EL3247), via an unspecified route of administration, administered in left arm as dose 1, single on 23Feb2021 (at the age of 63-year-old) for COVID-19 immunisation. Concomitant medications included atorvastatin (ATORVASTATIN) and sertraline hydrochloride (SERTRALINE HYDROCHLORIDE) both taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and received other medications within 2 weeks of vaccination with atorvastatin and sertraline hydrochloride. Patient had been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On 16Mar2021 at 19:00, the patient experienced sluggish, tired, muscle aches, face on fire, chills, sweating and headache. Patient did not receive any treatment for the adverse event. At the time of this report, the outcome of events was recovered on unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Got first shot August 2nd, had a positive pregnancy test Augsut 16th, ended up in the hospital August 23rd and had a miscarriage.
Narrative:  Patient states he "felt in a fog" and won down from 01/14-01/16. He also reports nausea on these days.  Other Relevant Hx: Symptoms:  NauseaVomiting & fatigue Treatment:
1st shot: small rash on chest, arms, tummy. slight swelling in face. Congestion.  2nd shot: Major rash chest, arms, legs, tummy and face. Major swelling on face. Horrible congestion.
Initial and follow-up information has been received from a Licensed Practical Nurse concerning a 20 year old female with no pertinent medical history and no drug allergies who on 05-JAN-2010 was vaccinated intramuscularly in right deltoid arm with the first 0.5 mL dose of GARDASIL (LOT# 0669Y). Concomitant therapy included DEPO-PROVERA. The patient felt numbness from head to toe right after receiving the vaccine. There was no lab diagnostic study performed. She recovered few minutes later. On 29-MAR-2010, a voice mail message was received from the nurse. It was reported that the patient received no other vaccines at the time of the GARDASIL vaccination. The nurse said that according to the patient directly after receiving the first dose, the patient was paralyzed on the right side for one minute. Even though medical staff was available, the patient did not tell them of this event. Therefore no treatment was given and no referrals were made. It wasn't until the patient came in for the second dose did the staff learn of the incident. The second dose of GARDASIL was not given. Upon internal review, paralyzed on the right side for one minute was determined to be an other important medical event. No further information is available.
Itching at body, intensified throughout day & into evening after receiving vaccine. Feeling of crawlies/tingling all over. Rash all over body. Pt felt tired-exhausted. Woke up in AM, rash decreased, itching decreased, however, achy. Patient called in at 7:30pm on 11/19/2012, concerned that she might have had a reaction to the flu shot she received at 1 pm, on 11/18/2012. She said she experienced itchiness that started after she received the shot and intensified during the course of the day and into the evening. She took 2 BENADRYL tabs (1 at 11:30pm, and 1 at 230am) hoping to help with the itching. She also mentioned that she felt "tingling/crawlies" all over her body with the itching that she experienced. No fever. She noticed that she developed that rash all over her body (which appeared BEFORE she scratched her itchy skin). In the evening, she felt exhausted but she couldn't sleep. She fell asleep at around 230 am (which could be a result of the BENADRYL). When she woke up at 630am, she was still itchy, but it's not as intense and the rash has decreased. She felt achy though. Pt currently has fibromyalgia, endometriosis and allergies which she gets shots for (her last appointment was 2 weeks ago). She has not started any new medications lately. I checked the monograph and I didn't find the side effects specifically addressing the "crawlies" that she experienced. I told her that the most common SE is the localized rash and the "achiness" she felt in the morning is also common. Pt mentioned that there is a possibility that it could be her fibromyalgia. I told her that we will call the MFR to verify any post marketing data about the "crawlies (the monograph mentioned "paresthesia" as a SE but I didn't know if the "crawlies" would fall under this guideline). I also called and left message for employee to call back about it tomorrow. Talk to her first before calling MFR. Pt has had shots of FLUVIRIN for 2010-11 and 2009-10 seasons at our pharmacy. Please call pt with any info. We might want to let her MD know about reaction to vaccine. If this seems like an "allergic" reaction (which it doesn't seem like it is), pls call Dr who is her allergist. 847pm per staff possibly urticaria syndrome. 849pm called pt & explained urticaria possibility with pt resolved. Call 911 if recurs, call MD 1st thing in am for follow-up.
Covid Like Symptoms including SOB, Aches, Low-Grade Fever , runny nose , cough
Patient should have received Moderna Bivalent but was given half-dose of Moderna primary series.
This case was reported by a consumer and described the occurrence of sickness in a female patient who received BEXSERO for prophylaxis. In September 2018, the patient received the 1st dose of BEXSERO. On an unknown date, less than a year after receiving BEXSERO, the patient experienced sickness and illness. On an unknown date, the outcome of the sickness and illness were unknown.  It was unknown if the reporter considered the sickness and illness to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. It was reported that was there any timeframe that the 2nd dose of BEXSERO could no longer be received as the patient got her 1st dose of BEXSERO in September and was very sick and did not end up getting 2nd injections due to illness. The reporter asked if she could receive the 2nd dose and get it covered or had to restart the injections and what was the last possible date to get an injection and it if it would still counted as part of the series. This case has been linked to the case US2019GSK010398 (second daughter), reported by same reporter.
I have white patches in my mouth, inside my lips, cheeks, back of throat, and on my tongue.; My tongue has swollen and inflamed taste buds all over it; This is a burning/tingling sensation and is worse when eating.; This is a burning/tingling sensation and is worse when eating.; This is a spontaneous report from a contactable nurse. This 33-year-old non-pregnant female nurse reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via intramuscular route of administration on 18Jan2021 on right arm (at 33-year-old), as dose 1, single and the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 08Feb2021 on right arm (at 33-year-old), as dose 2, single for COVID-19 immunization. The medical history of the patient included allergies to gabapentin and methocarbamol. The other medical history included psoriasis, hidradenitis suppurativa and migraines. The patient did not receive any other vaccine in four weeks. Concomitant medications included vitamin c (Ascorbic acid) 1000mg, zinc 30 mg, curcuma longa (Turmeric) 450 mg, cranberry, calcium 600 mg, colecalciferol (Vit D3) 2000 iU, biotin 10000 mg, fish oil 2000 mg, ashwagandha 500 mg, macrogol 3350 (Miralax) 17 g, plantago ovata (Metamucil Citron); docusate sodium (Colace) 400 mg, omeprazole 20 mg, guaifenesin (Mucinex) (1200 mg), pseudoephedrine (120 mg), pregabalin 100 mg, topiramate (100 mg), trazodone (150 mg); hydroxyzine (50 mg), sertraline hydrochloride (Zoloft) 100 mg, celecoxib (Celebrex) 200 mg; adalimumab (Humira); erenumab aooe (Aimovig) all were taken for an unspecified indication, start and stop date were not reported. The patient previously took gabapentin and experienced drug hypersensitivity, methocarbamol and experienced drug hypersensitivity. On 08Feb2021 patient used Abbott antigen test card and underwent nasal Swab test for covid post vaccination and tested negative. On 11Feb2021 the patient had white patches in her mouth, inside her lips, cheeks, back of throat, and on her tongue. The white patches were able to be sloughed off. She had no pain with the white patches or sore throat. Her tongue had swollen and had inflamed taste buds all over it. This was a burning/tingling sensation and was worse when eating. These symptoms occurred approximately 3 days after she received her second vaccine. The event resulted to visit to emergency room/department or urgent care. The patient received treatment with prednisone and valacyclovir. The patient had not recovered.  Information of lot/batch number had been requested.  Follow-up (13May2021): Follow-up attempts completed. No further information was expected.
disoriented; Fever; Headache; swollen lymph node under left armpit for 4 days; body aches; tiredness; mild nausea; This is a spontaneous case is received from a contactable consumer (patient). A 56-years-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 23Feb2021 15:00 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included hypertension, type 2 diabetes mellitus, high cholesterol and acid reflux. It was unknown if the patient had known allergies. The patient's concomitant medications were not reported. On 24Feb2021 at 02:00, the patient experienced disoriented, fever, headache, swollen lymph node under left armpit for 4 days, body aches, tiredness and mild nausea. Therapeutic measures were taken as a result of fever. The outcome of the events was recovering.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Approximately 5 minutes after tenivac immunization was given, patient had a syncopal episode that lasted less than one minute. Patient was sitting in a chair and loss consciousness. I was able to catch the patient and patient regained consciousness in less than one minute. Upon regaining consciousness, patient was assisted to the examination table and laid down and stated she felt better. After 3 minutes patient was assisted to sitting position but states she was beginning to feel nauseous and was assisted to laying position again. After 3 minutes patient's friend brought water and a granola bar and patient was assisted to a sitting position. Patient stated she had not eaten anything that day. After eating and drinking patient sat for another 10 minutes and did not complain of any additional symptoms.
Severe headache and fever.  Patient had continuous headache and intermittent fever for approximately 6 weeks after.
per mom redness began noc of shot & became worse when child presented to clinic on 8JAN arm was red, nod, swollen & painful per MD;edema rxn;DPH & warm compresses;